PMA device
INGEVITY MRI tined and extendable/retractable fixation leads / INGEVITY+ leads
Boston Scientific · Implantable Pulse Generator, Pacemaker (Non-Crt) (LWP, Class III) · First FDA decision Jul 27, 2017, newest Feb 20, 2026Bradycardia and heart block
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
4
PMA pathway
Device trials
10
Naming "INGEVITY"
MAUDE reports
45,718
Brand "INGEVITY", since 2015
PubMed studies
18
Mentioning "INGEVITY"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing INGEVITY MRI tined and extendable/retractable fixation leads / INGEVITY+ leads
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 4 of 4 decisions filed under this name.
P150012-S176 · Decided Feb 20, 2026 · 80 days after receipt · Normal 180 Day Track No User Fee
Device type: Implantable pulse generator, pacemaker (non-CRT) (LWP) · Cardiology
P150012-S078 · Decided Jul 31, 2019 · 89 days after receipt · Normal 180 Day Track
Device type: Implantable pulse generator, pacemaker (non-CRT) (LWP) · Cardiology
- INGEVITY MRI Leads, Slit Suture Sleeve Accessory for INGEVITY Leads (Pacing Leads and Accessories)PMA supplement
P150012-S032 · Decided Sep 20, 2017 · 117 days after receipt · Normal 180 Day Track
Device type: Implantable pulse generator, pacemaker (non-CRT) (LWP) · Cardiology
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "INGEVITY", any status and sponsor, newest update first.
- Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-upActive, not recruiting
Boston Scientific CorporationPublic (BSX)
NCT07209852 · 141 participants · Start Dec 19, 2025 · Primary completion Aug 31, 2029
Device: Pacemaker lead · For: Bradycardia; Atrioventricular Block; Sinus Node Dysfunction and 1 more
Sites: Bruges, Belgium; Brussels, Belgium; Lille, France · 13 sites in all
- SHort Of Pace - Heart Failure (SHOP-HF)Recruiting
Fundación para la Investigación del Hospital Clínico de ValenciaAcademic, hospital or other
NCT06992089 · 30 participants (planned) · Start Jun 17, 2025 · Primary completion Jun 2027
Device: Dual-chamber cardiac pacemaker (Proponent MRI L211/L231 or Accolade MRI L311/L331, Boston Scientific), single-chamber cardiac pacemaker (Essentio MRI L110 or Accolade MRI L310, Boston Scientific) · For: Heart Failure With Preserved Ejection Fraction
Sites: Valencia, Spain
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailurePivotal-lookingRecruiting
Boston Scientific CorporationPublic (BSX)
NCT07069738 · 850 participants (planned) · Start Oct 22, 2025 · Primary completion Nov 2029
Device: CRT-D with a Quadripolar LV lead; CRT-D with INGEVITY+ pace/sense lead · For: Heart Failure - NYHA II - IV
Sites: Huntsville, Alabama; Mobile, Alabama; Phoenix, Arizona · 43 sites in all
7 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "INGEVITY", and for the whole product code for context.
This brand
45,718 reports: 12,572 malfunction, 32,949 injury, 196 death
Whole product code LWP
142,226 reports: 58,138 malfunction, 82,585 injury, 1,486 death
Newest reports for this brand
- INGEVITY+Malfunction
2124215-2026-57730 · Received Oct 30, 2026 · Event dated Oct 15, 2026
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- INGEVITY+Injury
2124215-2026-57740 · Received Oct 30, 2026 · Event dated Oct 19, 2026
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- INGEVITY+Malfunction
2124215-2026-57739 · Received Oct 30, 2026 · Event dated Oct 16, 2026
Device type: Drug Eluting Permanent Right Ventricular (Rv) Or Right Atrial (Ra) Pacemaker Electrodes (NVN)
Device problem as coded: Insufficient Device Problem Information
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1770-2026 · Started Mar 19, 2026 · Posted by FDA Apr 24, 2026
Reason given: Updated software, Brady software maintenance release 6 (SMR6), is now available for the ACCOLADE" family of pacemakers and cardiac resynchronization therapy pacemakers (CRT-Ps)1 and the advisory population is expanding to include all CRT-P and dual-chamber extended life (DR-EL) devices. Dual chamber modes are...
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Implantable Pulse Generator, Pacemaker (Non-Crt) (LWP)
- ACCOLADE SR SL MRI (Model L310)Open, Classified
Z-0081-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025
Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...
Cause as FDA categorized it: Other · Device type: Implantable Pulse Generator, Pacemaker (Non-Crt) (LWP)
- ACCOLADE DR SL MRI (Model L311)Open, Classified
Z-0082-2026 · Started Aug 20, 2025 · Posted by FDA Oct 10, 2025
Reason given: Software to enhance Safety Architecture is available and designed to prevent initiation of Safety Mode in an ambulatory setting due to a high battery impedance state for the ACCOLADE family of devices which includes ACCOLADE, PROPONENT, ESSENTIO, and ALTRUA 2 dual chamber (DR) standard life (SL) and DR extended life...
Cause as FDA categorized it: Other · Device type: Implantable Pulse Generator, Pacemaker (Non-Crt) (LWP)
25 more recall records with a free account
Published research
The most relevant PubMed records for "INGEVITY"[tiab]. The summary above synthesizes these.
- Strategies to maximize lead tensile strength during extraction in three families of pacing leads.
Vatterott P, Finley J, Savela J, et al. · Heart Rhythm · 2024
- Comparative durability of pacemaker leads in transvenous lead extraction: An evaluation through bench testing.
Morita J, Okada A, Kusumoto F, et al. · Heart Rhythm O2 · 2025
- Increased incidence of electrical abnormalities in a pacemaker lead family.
Adelstein E, Zhang L, Nazeer H, et al. · J Cardiovasc Electrophysiol · 2021Observational Study
- Increased risk of lead transection and procedural complexity during extraction of thin-diameter, single filar pacemaker leads.
Sajja A, Mekary W, Huang J, et al. · Heart Rhythm · 2026
- Implantation Success, Electrical Performance, and Safety of an Active Fixation Stylet-Driven Lead for LBBAP in Clinical Practice: A Multicenter Experience.
Santoro A, Ziacchi M, Calvanese R, et al. · J Cardiovasc Electrophysiol · 2026Multicenter Study, Research Support, Non-U.S. Gov't
- Permanent his bundle pacing: Description and comparison of four implantation techniques.
Bontempi L, Fundaliotis A, Moretti M, et al. · Pacing Clin Electrophysiol · 2023
- Performance and Physician Experience of INGEVITY+ Active Fixation Leads: Prospective INGEVITY+ Lead Clinical Study in Korea.
Joung B, Bae MH, Oh IY, et al. · Cardiol Res Pract · 2024
- Strategies to increase the INGEVITY lead strength during lead extraction procedures based on laboratory bench testing.
Vatterott P, De Kock A, Hammill EF, et al. · Pacing Clin Electrophysiol · 2021
- Assessing Torque Transfer in Conduction System Pacing: Development and Evaluation of an Ex Vivo Model.
Chapman D, Morgan F, Tiver KD, et al. · JACC Clin Electrophysiol · 2024Research Support, Non-U.S. Gov't
- Conduction System Pacing With Stylet Driven Leads: A Step-By-Step Guide to Implant.
Burris R, Gampa A, Upadhyay GA · J Cardiovasc Electrophysiol · 2025Research Support, Non-U.S. Gov't
- Performance of an active fixation stylet-driven lead in left bundle branch area pacing: Results from INSIGHT-LBBA.
Friedman DJ, Shadrin I, Goldbarg S, et al. · Heart Rhythm · 2025Multicenter Study, Research Support, Non-U.S. Gov't
- Spontaneous Helix Retraction of the Ingevity+ Pacemaker Lead: A Single-Center Experience.
Monfredi O, Heard BZ, Zimmerman M, et al. · Circ Arrhythm Electrophysiol · 2021Letter
Other devices of this type
Also filed under product code LWP.
- CapSureFix MRI LeadMedtronic, Inc. · PMA 2025
- Revo MRI Surescan Ipg and Pacing SystemMedtronic, Inc. · PMA 2020
- Assurity MRI / Endurity MRI PacemakersAbbott Medical · PMA 2026
- Imageready MR Conditional Pacing System and Ingevity Pace/Sense LeadBoston Scientific · PMA 2026
- Tendril MRI Pacing Leads / Assurity MRIAbbott Medical · PMA 2025
- Percepta Quad CRT-P MRI SureScanMedtronic, Inc. · PMA 2019
- AdvantioBoston Scientific Corp · PMA 2018
- Acuity Spiral LeadBoston Scientific Corp · PMA 2013
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.